B of A Securities Downgrades Novartis to Neutral, Lowers Price Target to $130
Portfolio Pulse from Benzinga Newsdesk
B of A Securities has downgraded Novartis from Buy to Neutral and reduced its price target from $135 to $130.

September 11, 2024 | 10:29 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
B of A Securities downgraded Novartis from Buy to Neutral and reduced the price target from $135 to $130, indicating a less optimistic outlook.
The downgrade from Buy to Neutral by a major analyst like B of A Securities typically suggests a less favorable view on the stock's potential performance. The reduction in the price target further supports this sentiment, likely leading to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100